An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institutes of Health)
Michigan State University scientists have invented a new way to monitor chemotherapy concentrations. Too high a dose can result in killing healthy tissue and cells, triggering more side effects; too low a dose may stun, rather than kill, cancer cells, allowing them to come back. The new process is based around magnetic particle imaging that uses superparamagnetic nanoparticles as the contrast agent and the sole signal source to monitor drug release in the body at the site of the tumor.
